Congenital adrenal hyperplasia
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive genetic disorders that affect the adrenal glands. These disorders are characterized by impaired ability of the adrenal glands to produce corticosteroids, which are essential for various bodily functions.
Etiology
CAH is caused by mutations in genes that encode enzymes involved in the production of corticosteroids. The most common form of CAH, accounting for about 95% of cases, is due to a deficiency in the enzyme 21-hydroxylase. Other less common forms of CAH are caused by deficiencies in the enzymes 11β-hydroxylase, 17α-hydroxylase, 3β-hydroxysteroid dehydrogenase, and P450 oxidoreductase.
Clinical Presentation
The clinical presentation of CAH varies depending on the specific enzyme deficiency and the severity of the mutation. Symptoms can range from mild to severe and may include virilization or feminization, early onset of puberty, infertility, and potentially life-threatening adrenal crisis.
Diagnosis
Diagnosis of CAH is typically made through a combination of clinical examination, biochemical testing, and genetic testing. Biochemical testing involves measuring levels of specific hormones in the blood or urine, while genetic testing involves analyzing the DNA for mutations in the relevant genes.
Treatment
Treatment for CAH primarily involves hormone replacement therapy to correct the deficiency in corticosteroids. In some cases, surgery may be required to correct anatomical abnormalities resulting from the disorder.
Prognosis
With appropriate treatment, individuals with CAH can lead normal lives. However, they may require lifelong medication and regular medical follow-up.
See Also
| Endocrine, nutritional and metabolic diseases | ||||||
|---|---|---|---|---|---|---|
This endocrine, nutritional and metabolic disease related article is a stub.
|
| Genetic disorders | ||||||||
|---|---|---|---|---|---|---|---|---|
This genetic disorder related article is a stub.
|

This article is a pediatrics stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian